Initial treatment choices for long‐term remission of chronic insomnia disorder in adults: a systematic review and network meta‐analysis
Open Access
- 26 August 2024
- journal article
- review article
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 78 (11) , 646-653
Abstract
Background: We aimed to evaluate the comparative efficacy and acceptability of cognitive behavioral therapy for insomnia (CBT‐I), pharmacotherapy, and their combination in the long and short terms among adults with chronic insomnia disorder.Methods: We searched multiple databases to December 27, 2023. We included trials in hypnotic‐free adults with chronic insomnia comparing at least two of CBT‐I, pharmacotherapy, or their combination. We assessed the confidence in evidence using CINeMA. The primary outcome was long‐term remission. Secondary outcomes included all‐cause dropout and self‐reported sleep continuity measures in the long term, and the same outcomes in the short term. We performed frequentist random‐effects network meta‐analyses (CRD42024505519).Findings: We identified 13 trials including 823 randomized participants (mean age, 47.8 years; 60% women). CBT‐I was more beneficial than pharmacotherapy in the long term (median duration, 24 weeks [range, 12 to 48 weeks]; remission odds ratio, 1.82 [95% confidence interval (CI), 1.15–2.87]; [certainty of evidence: high]), while there was weaker evidence of benefit of combination against pharmacotherapy (1.71 [95% CI, 0.88–3.30: moderate]) and no clear difference of CBT‐I against combination (1.07 [95% CI, 0.63–1.80: moderate]). CBT‐I was associated with fewer dropouts than pharmacotherapy. Short‐term outcomes favored CBT‐I over pharmacotherapy except total sleep time. Given the average long‐term remission rate in the pharmacotherapy‐initiating arms of 28%, CBT‐I resulted in a long‐term remission rate of 41% (95% CI, 31%–53%) and combination 40% (95% CI, 25%–56%).Interpretation: The current study found that starting with CBT‐I for chronic insomnia leads to better outcomes than pharmacotherapy. Combination may be better than pharmacotherapy alone, but unlikely to be worth the additional burden over CBT‐I alone.Keywords
This publication has 45 references indexed in Scilit:
- Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in AdultsJAMA Psychiatry, 2024
- Benzodiazepine Use During Pregnancy and Risk of MiscarriageJAMA Psychiatry, 2024
- Effectiveness of Sequential Psychological and Medication Therapies for Insomnia DisorderJAMA Psychiatry, 2020
- Consistency and inconsistency in network meta‐analysis: model estimation using multivariate meta‐regressionResearch Synthesis Methods, 2012
- ExpectationsJournal of Clinical Psychology, 2010
- Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly PersonsArchives of internal medicine (1960), 2009
- Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent InsomniaJAMA, 2009
- Cognitive Behavioral Therapy vs Zopiclone for Treatment of Chronic Primary Insomnia in Older AdultsJAMA, 2006
- Cognitive Behavior Therapy and Pharmacotherapy for InsomniaArchives of internal medicine (1960), 2004
- Behavioral and Pharmacological Therapies for Late-Life InsomniaJAMA, 1999